Researchers published a comment in BMC Artificial Intelligence in June 2025, arguing that artificial intelligence offers a transformative approach to addressing the global crisis of antimicrobial resistance. The article, titled “Harnessing artificial intelligence for predictive modeling in combating antimicrobial resistance: a call for integration and innovation,” emphasizes the urgent need for innovative solutions to mitigate the socioeconomic and public health implications of resistant microorganisms. The authors, including Adamu Muhammad Ibrahim and Don Lucero-Prisno Eliso III, highlight that the rise of resistant pathogens undermines the effectiveness of antibiotics, antivirals, and antifungals, leading to increased mortality and prolonged illnesses. This commentary underscores the potential of AI to serve as a critical tool in safeguarding global public health by integrating advanced computational methods into healthcare systems.
Antimicrobial resistance is described as a critical global health challenge with profound implications for both developed and developing nations. The burden of AMR is disproportionately high in low- and middle-income countries, with specific data indicating that Sub-Saharan Africa had the highest rate of AMR burden at 23.7 deaths per 100,000 people. In contrast, Australasia recorded the lowest rate at 6.5 deaths per 100,000. Infections caused by antimicrobial-resistant organisms are difficult to treat and carry an increased chance of severe illness and eventual death due to their debilitating effect on the host system. The authors note that this pandemic of resistance requires swift, coordinated efforts worldwide to achieve one health coverage and reduce associated medical expenses and mortality rates.
A major barrier to reducing the excessive use of antimicrobials is their pervasive incorporation into food, animal production, and medical treatment. Modern farming systems rely on the routine administration of antimicrobials to animals for infection control and growth promotion, while doctors frequently rely on empirical antibiotic prescriptions due to the lack of rapid point-of-care diagnostics. The epidemic is further exacerbated by improper use of antibiotics and insufficient infection control measures. Despite high levels of knowledge regarding the hazards of antibiotic abuse, antimicrobial stewardship programs in healthcare settings and updated animal husbandry rules remain not widely implemented. Additionally, the pipeline for developing newer and more effective drugs is unable to keep up with the ongoing evolution of multidrug-resistant bacteria, posing a growing threat that could kill millions of people every year.
In response to these challenges, the authors propose artificial intelligence and machine learning as urgently required innovative strategies. AI is characterized as a cutting-edge strategy that accelerates the development of new drugs due to its rapid pace, cost-effectiveness, reduced labor needs, and decreased failure rate. The technology has already been applied in the discovery of several β-lactamase inhibitors and substitutes for antibiotics from marine natural products, non-ribosomal peptides, antimicrobial peptides, and bacteriocins. AI serves as a useful tool for preventing AMR by accelerating and enhancing traditional procedures, guaranteeing intelligent digitalized patient care, and reducing human-based errors in healthcare systems.
Deep learning, a specialized subset of machine learning that processes data using artificial neural networks with several layers, plays a significant role in this predictive modeling. A recent study developed the MSDeepAMR model, which uses deep learning techniques to analyze raw mass spectrometry data for predicting AMR in bacterial species such as Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Considering the sheer amount of biological data generated and embedded in body systems, analyzing and interpreting this data is paramount for understanding the molecular and cellular processes that foster AMR outcomes. The use of AI and ML in developing predictive models allows for the prediction of AMR patterns by processing vast datasets.
Several studies have demonstrated the effectiveness of machine learning models in predicting AMR microorganisms and their resistance to broad- and narrow-spectrum antibiotics. These models utilize patient data, microbiology test results, and other relevant features to train algorithms such as XGBoost, LightGBM, and Random Forest to accurately predict antibiotic resistance. High accuracy, sensitivity, and specificity scores have been achieved, indicating the potential of these models to guide empirical antibiotic therapy. AI can analyze large datasets to uncover complex interactions and factors driving AMR, including patient demographics, comorbidities, antibiotic usage patterns, and environmental conditions. By identifying these critical determinants, AI models can predict how resistance forms and spreads in various settings, particularly in poorly developed areas.
Predictive AI models can also be employed in early warning systems to identify rising resistance patterns and outbreaks across a global radar. By continuously monitoring data sources, these systems can provide timely alerts to healthcare providers, policymakers, and public health authorities, enabling proactive interventions to contain the spread of resistant pathogens. AI-powered models can forecast an individual patient’s probability of harboring resistant infections, thereby promoting a personalized medicine approach. This allows clinicians to adjust antibiotic selection and dosage according to the patient’s specific profile, improve treatment outcomes, and minimize the selective pressure for resistance.
Furthermore, AI can analyze massive datasets from clinical and environmental sources, revealing insights and trends linked to AMR in humans, animals, and plants. AI and ML algorithms can be trained on comprehensive datasets that integrate clinical data, such as patient records and microbiological test results, and environmental data, including antibiotic usage patterns, pollution levels, and climate. These models allow for proactive interventions by predicting the formation and spread of diseases with resistance under various conditions. This information can help focus measures, such as improving antibiotic stewardship or reducing environmental pollution, to target the underlying causes of resistance. With the use of AI, a precision approach can enhance treatment results and reduce the selective pressure for resistance.
Despite the tremendous opportunities, the integration of AI in combating AMR faces various hurdles and weaknesses. Understanding these limits is vital for effectively harnessing AI technology in this critical field of public health. Some of the challenges include data availability and model quality, where inadequate data might cause biased models that do not generalize well to real-world settings. Lack of transparency can undermine confidence among healthcare professionals and stakeholders, who may be hesitant to depend on AI-driven suggestions without understanding the underlying decision-making process. Healthcare providers may also show resistance due to worries about reliability and the requirement for training in new technology.
The application of AI in healthcare involves ethical considerations, such as patient privacy, data security, and the possibility of algorithmic prejudice. These aspects must be carefully handled to ensure that AI applications do not unintentionally increase existing inequities in healthcare access and outcomes. The authors argue that the increasing threat posed by AMR necessitates an interdisciplinary response that makes use of AI in cooperation with important players in both public and private sectors. The effective integration of AI to anticipate, identify, and control AMR will require close cooperation among public health officials, microbiologists, doctors, and AI specialists.
To fully realize AI’s promise in the fight against AMR, long-term policy support and committed financing are required. Governments and international organizations must prioritize AMR as a global health security problem and engage in programs to promote AI innovation and integration into healthcare systems. AI can be used to forecast, detect, and control the growing threat of antibiotic resistance by adopting a multidisciplinary approach, obtaining government support and financing, and utilizing the complementary skills of the public and private sectors. This collective effort is critical for protecting the global public health system and ensuring a sustainable future free from AMR.
In conclusion, AMR continues to pose a rising concern to global health, particularly in resource-limited settings. Artificial intelligence provides a holistic solution to this problem by facilitating quick diagnoses, predictive modeling, surveillance, and medication discovery. However, its successful integration into healthcare systems necessitates strong data infrastructures, transparent and ethical AI systems, interdisciplinary collaboration, and ongoing policy backing. Investing in AI-based technologies and building a global coalition are critical to guaranteeing a future in which antimicrobial resistance is efficiently tracked, managed, and minimized. The authors call for robust policy frameworks, dedicated funding, and global partnerships to integrate AI into healthcare systems for AMR surveillance, prevention, and control.
Subject of Research: Integration of artificial intelligence for predictive modeling in antimicrobial resistance management
Article Title: Harnessing artificial intelligence for predictive modeling in combating antimicrobial resistance: a call for integration and innovation
Article References: Ibrahim, A. M., Ahmed, M. M., Musa, S. S., Haruna, U. A., Hamid, M. R., Adedokun, A. I., Saleh, A. M., & Eliso, D. L.-P., III (2025). Harnessing artificial intelligence for predictive modeling in combating antimicrobial resistance: a call for integration and innovation. BMC Artificial Intelligence, 1(1), Article 1. https://doi.org/10.1186/s44398-025-00001-w
Image Credits: AI Generated
DOI: 10.1186/s44398-025-00001-w
Keywords: Antimicrobial Resistance, Artificial Intelligence, Predictive Modeling, Machine Learning, Public Health, Drug Discovery, Healthcare Systems, Global Health, Harnessing, artificial, intelligence, predictive
News Source: Naomi Webster. (November 9, 2026). AI Predictive Models Aim to Combat Antimicrobial Resistance. Scienmag.
